Literature DB >> 4858784

Analysis of the in vitro product of an RNA-dependent RNA polymerase isolated from influenza virus-infected cells.

L A Caliguiri, R W Compans.   

Abstract

The products synthesized in vitro by an RNA-dependent RNA polymerase isolated from influenza virus-infected BHK21-F cells were analyzed by velocity sedimentation, annealing techniques, and acrylamide-agarose gel electrophoresis. Approximately 50% of the RNA synthesized in vitro remains associated with the 50 to 70S ribonucleoprotein complex containing polymerase activity; the remainder of the RNA polymerase product sediments heterogeneously with a peak at 13S. At least 90% of the in vitro product hybridizes with virion RNA. If polypeptides are labeled early in the growth cycle, both the P and NP polypeptides are detected in the ribonucleoprotein complex by acrylamide gel electrophoresis. The results suggest that the polypeptide composition and the products of the cell-associated RNA polymerase are similar to those of the RNA transcriptase associated with influenza virus particles.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4858784      PMCID: PMC355502          DOI: 10.1128/JVI.14.2.191-197.1974

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  RNA-dependent RNA polymerase activity associated with virions and subviral particles of myxoviruses.

Authors:  N L Chow; R W Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

2.  Ribonucleic acid nucleotidyl transferase induced in chick fibroblasts after infection with an influenza virus.

Authors:  C Scholtissek; R Rott
Journal:  J Gen Virol       Date:  1969-01       Impact factor: 3.891

3.  Ribonucleic acid synthesis in chick embryo cells infected with fowl-plague virus.

Authors:  J J Skehel; D C Burke
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

4.  Polyacrylamide gel electrophoresis of influenza virus RNA.

Authors:  M W Pons; G K Hirst
Journal:  Virology       Date:  1968-02       Impact factor: 3.616

5.  Synthesis in vitro of RNA complementary to parental viral RNA by RNA polymerase induced by influenza virus.

Authors:  C Scholtissek
Journal:  Biochim Biophys Acta       Date:  1969-04-22

6.  Distinct subunits of the ribonucleoprotein of influenza virus.

Authors:  P H Duesberg
Journal:  J Mol Biol       Date:  1969-06-28       Impact factor: 5.469

7.  The detection and characterization of an induced RNA polymerase in the chorioallantoic membranes of embryonated eggs infected with influenza A2 virus.

Authors:  B J Ruck; K W Brammer; M G Page; J D Coombes
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

8.  Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins.

Authors:  R W Compans; H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity.

Authors:  P W Choppin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

10.  On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types.

Authors:  K V Holmes; P W Choppin
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  3 in total

1.  Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis.

Authors:  R M Krug; M Ueda; P Palese
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

2.  RNAs of influenza virus recombinants derived from parents of known virulence for man.

Authors:  G Florent; M Lobmann; A S Beare; N Zygraich
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  P1 and P3 proteins of influenza virus are required for complementary RNA synthesis.

Authors:  P Palese; M B Ritchey; J L Schulman
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.